Is Weed Legal in Maryland?

Yes — Maryland voters approved Question 4 in November 2022, authorizing recreational cannabis use for adults 21 and older. The state legislature passed the enabling legislation (HB 556 and SB 516) in 2023, and licensed recreational retail sales began on July 1, 2023. Maryland became the 22nd state to legalize recreational cannabis.

The Maryland Cannabis Administration (formerly the Maryland Medical Cannabis Commission — MMCC) oversees licensing, testing, and compliance for both recreational and medical markets. Maryland’s existing medical dispensary infrastructure converted to dual-use operations on July 1, 2023, providing immediate recreational retail access across the state.

Possessing between 1.5 oz and 2.5 oz is a civil fine of up to $250. Possession of more than 2.5 oz may result in a misdemeanor charge. Possession with intent to distribute carries felony charges. Public consumption is a civil offense with fines.

Maryland allows adults 21+ to grow up to 2 mature cannabis plants per person at their primary residence, with a household maximum of 4 mature plants. This limit took effect simultaneously with recreational retail sales on July 1, 2023. Plants must be grown in a secure location, not visible from a public way or adjacent property, and must be in an area inaccessible to individuals under 21.

There is no license required for personal home cultivation within these limits. Individuals may possess cannabis harvested from their own plants in addition to the public possession limit for purchased cannabis. Selling or transferring home-grown cannabis without a license is prohibited.

Maryland established its medical cannabis program in 2014, with patient access beginning in 2016. The program was administered by the Maryland Medical Cannabis Commission until the Commission transitioned into the Cannabis Administration in 2023. Medical patients with registry identification cards retain legacy protections and higher purchase limits under the combined system.

Qualifying conditions include PTSD, chronic pain, anorexia, glaucoma, seizures, severe nausea, and any other condition for which a physician believes cannabis may provide benefit. Patients register through the Cannabis Administration and must renew their certification. Medical patients are exempt from the cannabis excise tax, paying only the standard 6% sales tax.

Maryland’s transition to a unified regulatory body under the Cannabis Administration was designed to streamline oversight and allow medical licensees to serve both patient and recreational consumer populations without duplicating compliance costs.

Maryland intentionally set its initial cannabis tax rate lower than most recreational states to remain competitive with the unregulated market and neighboring jurisdictions. Average retail prices in the Baltimore–Washington corridor typically run $10–$16 per gram for flower after tax, with higher prices for premium concentrates and edibles. The 40% social equity license set-aside is intended to ensure diverse ownership in the market as it expands.

The Maryland Cannabis Public Health and Safety Act reserves 40% of new cannabis licenses for social equity applicants. Eligibility is based on residence in or ownership by individuals from areas disproportionately impacted by cannabis enforcement, prior cannabis convictions, or immediate family members of individuals with such convictions.

Social equity applicants receive expedited review, reduced licensing fees, and priority placement in the licensing queue. The state has also established a Cannabis Business Assistance Fund to provide capital access and technical assistance to equity licensees, addressing one of the primary barriers to entry in the cannabis industry.

Maryland’s equity framework was developed with input from advocacy organizations and communities in Baltimore City and Prince George’s County, which experienced disproportionately high cannabis arrest rates during prohibition.

Maryland does not have a per se blood THC nanogram limit for cannabis DUI. Law enforcement uses standard field sobriety tests and Drug Recognition Expert assessments. Driving while impaired by cannabis (DWI) is a misdemeanor; driving under the influence (DUI) is a more serious charge. Both carry license suspension, fines, and potential jail time.

On employment: Maryland employers currently retain the right to drug-test employees and to maintain drug-free workplace policies. Workers do not yet have statutory protections for off-duty recreational cannabis use. Employment protection legislation has been introduced and is under consideration in the General Assembly. Medical cannabis patients may have some protections under the Americans with Disabilities Act framework depending on the circumstances, though this remains legally complex.

On-site consumption permits are available for licensed retailers under certain conditions, allowing cannabis lounges to operate in conjunction with dispensaries in jurisdictions that opt in.

Maryland’s proximity to Washington DC creates unique considerations. Washington DC permits adult possession and gifting of cannabis under Initiative 71 but lacks licensed retail sales (Congress has historically blocked DC from taxing cannabis). As a result, many DC-area residents cross into Maryland or Virginia to purchase from licensed retailers.

Transporting cannabis purchased in Maryland into Washington DC crosses a jurisdictional boundary but does not cross into a state with prohibition; however, federal land within DC (most of the city’s public areas) remains subject to federal law. Maryland residents should not transport cannabis across state lines or onto federal property regardless of destination jurisdiction.